research use only

Pitavastatin HMG-CoA Reductase inhibitor

Cat.No.E6038

Pitavastatin (NK-104) is a highly potent inhibitor of HMG-CoA reductase with an IC50 of 6.8 nmol/L, which significantly enhances LDL receptor activity and lowers LDL cholesterol (LDL-C) levels. It also inhibits cholesterol synthesis in vitro and has the potential to manage hypercholesterolemia and reducing cardiovascular risk. 
Jump to

Quality Control

Batch: E603801 DMSO]84 mg/mL]false]Ethanol]42 mg/mL]false]Water]Insoluble]false Purity: 98.20%
98.20

Solubility

In vitro
Batch:

DMSO : 84 mg/mL (199.3 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Ethanol : 42 mg/mL

Water : Insoluble

Molarity Calculator

Mass Concentration Volume Molecular Weight
Dilution Calculator Molecular Weight Calculator

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Chemical Information, Storage & Stability

Molecular Weight 421.46 Formula

C25H24FNO4

Storage (From the date of receipt)
CAS No. 147511-69-1 Download SDF Storage of Stock Solutions

Read more about storage stability stock solution CAS number

Mechanism of Action

References

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2025-08-07)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT06722521 RECRUITING
Primary Prevention; Vascular Calcification
Asan Medical Center
2025-07-09 PHASE4
NCT06767774 RECRUITING
ASCVD; Diabetes; Statin
Korea University Anam Hospital
2025-04-25 PHASE4
NCT07626840 NOT_YET_RECRUITING
Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)
Samsung Medical Center
2026-06-01
NCT07774975 NOT_YET_RECRUITING
Retinitis Pigmentosa (RP)
Kyushu University
2026-09-15 PHASE1
NCT07460960 RECRUITING
Erectile Dysfunction Due to Arterial Disease; Atheroscleroses; Erectile Disfunction; Endothelial Dysfunction; Androgen Profile; Testosterone
Lomonosov Moscow State University Medical Research and Educational Center
2026-03-05 PHASE2
NCT05705804 RECRUITING
Dyslipidemias; Atherosclerotic Cardiovascular Disease
Yonsei University
2023-06-13

Read more about Clinical Trials

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Signaling Pathway Map